SERONEGATIVE CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME IN A YOUNG FEMALE PRESENTING WITH A HEADACHE

被引:3
作者
Losonczy, Lia I. [1 ]
Johnson, Brian [1 ]
Sidhu, Jasmine [1 ]
Li, Jessica [1 ]
Feeney, Colin M. [1 ,2 ]
机构
[1] Alameda Hlth Syst Highland Hosp, Dept Emergency Med, Oakland, CA 94602 USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
catastrophic antiphospholipid syndrome; antiphospholipid syndrome; emergency services; autoimmune polyglandular syndrome; AUTOIMMUNE POLYENDOCRINE SYNDROMES; INTERNATIONAL CONSENSUS STATEMENT; CLASSIFICATION CRITERIA; MEDICAL PROGRESS; SYNDROME APS; ANTIBODIES; DISEASE;
D O I
10.1016/j.jemermed.2014.06.031
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Catastrophic antiphospholipid syndrome (CAPS) is a rare disease that causes rapid vascular occlusion in multiple organ systems. Initial presentation varies depending on the organs affected. Although headache is a common complaint in the emergency department (ED), it is a very rare presentation of CAPS. Case Report: A 43-year-old previously healthy woman presented to the ED with severe headache. Subarachnoid hemorrhage was excluded and she was discharged home. She returned 36 h later with diabetic ketoacidosis, hyperthyroidism, and thrombosis in her cerebral venous sinus, aorta and splenic artery. She was treated with heparin, steroids, plasmapharesis, and i. v. immunoglobulin, after which she improved. This constellation of symptoms is highly suggestive of CAPS initiated by a polyglandular autoimmune syndrome, despite negative serology. Why Should an Emergency Physician Be Aware of This?: Although a rare cause of headache, CAPS is a potentially fatal disease that requires early identification and initiation of appropriate treatment. (C) 2015 Elsevier Inc.
引用
收藏
页码:294 / 297
页数:4
相关论文
共 20 条
[1]   Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines [J].
Asherson, RA ;
Cervera, R ;
de Groot, PG ;
Erkan, D ;
Boffa, MC ;
Piette, JC ;
Khamashta, MA ;
Shoenfeld, Y .
LUPUS, 2003, 12 (07) :530-534
[2]  
ASHERSON RA, 1992, J RHEUMATOL, V19, P508
[3]  
ASHERSON RA, 1989, J RHEUMATOL, V16, P378
[4]   Antiphospholipid antibodies and the antiphospholipid syndrome: Clinical significance and treatment [J].
Asherson, Ronald A. ;
Cervera, Ricard ;
Merrill, Joan T. ;
Erkan, Doruk .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (03) :256-266
[5]  
Asherson RA, 2008, J RHEUMATOL, V35, P1224
[6]   Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction [J].
Betterle, C ;
Dal Pra, C ;
Mantero, F ;
Zanchetta, R .
ENDOCRINE REVIEWS, 2002, 23 (03) :327-364
[7]   Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome [J].
Cervera, R ;
Font, J ;
Gómez-Puerta, JA ;
Espinosa, G ;
Cucho, M ;
Bucciarelli, S ;
Ramos-Casals, M ;
Ingelmo, M ;
Piette, JC ;
Shoenfeld, Y ;
Asherson, RA .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1205-1209
[8]   CAPS Registry [J].
Cervera, R. .
LUPUS, 2012, 21 (07) :755-757
[9]   Medical progress - Autoimmune polyendocrine syndromes [J].
Eisenbarth, GS ;
Gottlieb, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (20) :2068-2079
[10]   Catastrophic antiphospholipid syndrome - Where do we stand? [J].
Erkan, D ;
Cervera, R ;
Asherson, RA .
ARTHRITIS AND RHEUMATISM, 2003, 48 (12) :3320-3327